Abstract
Abstract Background: Acne vulgaris is a long-term inflammatory condition impacting the pilosebaceous units. The guidelines largely rely on expert opinions in light of certain facets of acne treatment. Before initiating our study, we conducted a prescription analysis involving 100 patients diagnosed with acne vulgaris. We noted that in the majority of these cases, the established guidelines were not adhered to. Therefore, we decided to conduct this study at our institute to see if there is any additional benefit of adding multiple drugs to the treatment regimen and to find out if there is a way to rationalize the same. Materials and Methods: For the study, 120 patients with acne vulgaris, graded 2 and 3 according to the Investigator’s Global Assessment (IGA) Scale, were enrolled and divided into four groups. Patients were followed up for 8 weeks with visits at 4, 6, and 8 weeks. Group A was given clindamycin gel, Group B was given clindamycin gel + benzoyl peroxide gel (BPO) (2.5%), Group C was given clindamycin gel + BPO gel (2.5%) + oral doxycycline 100 mg, and Group D was given clindamycin gel + BPO gel (2.5%) + oral isotretinoin 20 mg. Results: This study showed that combination therapy with isotretinoin showed maximum reduction in IGA as well as in the total number of inflammatory lesions. Group C had similar efficacy to combination therapy with Group D as the results were not significantly different. Conclusions: The guidelines recommend adhering to protocols, specifically reserving isotretinoin for cases of very severe and treatment-resistant acne.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Datta Meghe Institute of Medical Sciences University
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
